Mon, Oct 28, 2024
Led by growth in its domestic business, the specialty generic pharma company is expected to post good July-September quarter.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.